{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:48:07Z","timestamp":1790729287577,"version":"4.1.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/mnm.0b013e32832ee93b","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T08:22:04Z","timestamp":1257841324000},"page":"908-917","source":"Crossref","is-referenced-by-count":78,"title":["Molecular PET and PET\/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation"],"prefix":"10.1097","volume":"30","author":[{"given":"Tara","family":"Barwick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badreddine","family":"Bencherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Mountz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210212","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1172\/JCI104111","article-title":"The metabolism and fate of tritiated thymidine in man","volume":"39","author":"Rubini","year":"1960","journal-title":"J Clin Invest"},{"key":"R2-3-20210212","first-page":"5698","article-title":"Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies","volume":"62","author":"Wells","year":"2002","journal-title":"Cancer Res"},{"key":"R3-3-20210212","first-page":"615","article-title":"2-[C-11]thymidine imaging of malignant brain tumors","volume":"59","author":"Eary","year":"1999","journal-title":"Cancer Res"},{"key":"R4-3-20210212","first-page":"1757","article-title":"Carbon-11-thymidine and FDG to measure therapy response","volume":"39","author":"Shields","year":"1998","journal-title":"J Nucl Med"},{"key":"R5-3-20210212","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1073\/pnas.69.4.988","article-title":"Detection of DNA synthesis in intact organisms with positron-emitting (methyl- 11C)thymidine","volume":"69","author":"Christman","year":"1972","journal-title":"Proc Natl Acad Sci"},{"key":"R6-3-20210212","first-page":"581","article-title":"Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds","volume":"33","author":"Shields","year":"1992","journal-title":"J Nucl Med"},{"key":"R7-3-20210212","first-page":"624","article-title":"Imaging brain tumor proliferative activity with [124I]iododeoxyuridine","volume":"60","author":"Blasberg","year":"2000","journal-title":"Cancer Res"},{"key":"R8-3-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0969-8051(00)00189-X","article-title":"[76Br]Bromodeoxyuridine PET in tumor-bearing animals","volume":"28","author":"Gardelle","year":"2001","journal-title":"Nucl Med Biol"},{"key":"R9-3-20210212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0969-8051(03)00081-7","article-title":"Development of radioiodinated nucleoside analogs for imaging tissue proliferation: comparisons of six 5-iodonucleosides","volume":"30","author":"Toyohara","year":"2003","journal-title":"Nucl Med Biol"},{"key":"R10-3-20210212","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","article-title":"Imaging proliferation in vivo with [F-18]FLT and positron emission tomography","volume":"4","author":"Shields","year":"1998","journal-title":"Nat Med"},{"key":"R11-3-20210212","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-004-1687-6","article-title":"[18F]FLT-PET in oncology: current status and opportunities","volume":"31","author":"Been","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"R12-3-20210212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00259-006-0134-2","article-title":"Is 3\u2032-deoxy-3\u2032-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?","volume":"33","author":"Reske","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-3-20210212","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.36.4.808","article-title":"Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3\u2032-fluoro-3\u2032-deoxythymidine and 3\u2032-azido-3\u2032-deoxythymidine","volume":"36","author":"Kong","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-3-20210212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0065-2571(93)90021-5","article-title":"Nucleoside transport in normal and neoplastic cells","volume":"33","author":"Belt","year":"1993","journal-title":"Adv Enzyme Regul"},{"key":"R15-3-20210212","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s00259-002-0851-0","article-title":"Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3\u2032-[(18)F]fluoro-3\u2032-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines","volume":"29","author":"Seitz","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-3-20210212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0065-2571(94)00014-T","article-title":"Human thymidine kinase 1. Regulation in normal and malignant cells","volume":"35","author":"Munch-Petersen","year":"1995","journal-title":"Adv Enzyme Regul"},{"key":"R17-3-20210212","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(19)57403-8","article-title":"Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells","volume":"263","author":"Sherley","year":"1988","journal-title":"J Biol Chem"},{"key":"R18-3-20210212","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0969-8051(99)00104-3","article-title":"Radiosynthesis of 3\u2032-deoxy-3\u2032-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo","volume":"27","author":"Grierson","year":"2000","journal-title":"Nucl Med Biol"},{"key":"R19-3-20210212","first-page":"371","article-title":"Kinetic modeling of 3\u2032-deoxy-3\u2032-fluorothymidine in somatic tumors: mathematical studies","volume":"46","author":"Muzi","year":"2005","journal-title":"J Nucl Med"},{"key":"R20-3-20210212","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00259-005-1813-0","article-title":"A simplified analysis of [18F]3\u2032-deoxy-3\u2032-fluorothymidine metabolism and retention","volume":"32","author":"Shields","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-3-20210212","first-page":"1210","article-title":"Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells","volume":"43","author":"Rasey","year":"2002","journal-title":"J Nucl Med"},{"key":"R22-3-20210212","first-page":"3315","article-title":"In vivo validation of 3\u2032deoxy-3\u2032-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors","volume":"8","author":"Vesselle","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R23-3-20210212","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-003-1257-3","article-title":"[18F]FLT PET for diagnosis and staging of thoracic tumours","volume":"30","author":"Dittmann","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R24-3-20210212","first-page":"1426","article-title":"Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG","volume":"44","author":"Buck","year":"2003","journal-title":"J Nucl Med"},{"key":"R25-3-20210212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/aid.1988.4.457","article-title":"Enhanced in vitro inhibition of HIV-1 replication by 3\u2032-fluoro-3\u2032-deoxythymidine compared to several other nucleoside analogs","volume":"4","author":"Hartmann","year":"1988","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R26-3-20210212","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/infdis\/170.6.1394","article-title":"Relationship between plasma concentrations of 3\u2032-deoxy-3\u2032-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials","volume":"170","author":"Flexner","year":"1994","journal-title":"J Infect Dis"},{"key":"R27-3-20210212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2385-7-3","article-title":"Toxicology evaluation of radiotracer doses of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine (18F-FLT) for human PET imaging: laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses","volume":"7","author":"Turcotte","year":"2007","journal-title":"BMC Nucl Med"},{"key":"R28-3-20210212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11307-008-0151-6","article-title":"NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies","volume":"10","author":"Spence","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"R29-3-20210212","first-page":"1482","article-title":"18F-Fluorothymidine radiation dosimetry in human PET imaging studies","volume":"44","author":"Vesselle","year":"2003","journal-title":"J Nucl Med"},{"key":"R30-3-20210212","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0969-8051(01)00289-X","article-title":"A new precursor for the radiosynthesis of [18F]FLT","volume":"29","author":"Martin","year":"2002","journal-title":"Nucl Med Biol"},{"key":"R31-3-20210212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0969-8051(02)00409-2","article-title":"High radiochemical yield synthesis of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine using (5'-O-dimethoxytrityl-2\u2032-deoxy-3\u2032-O-nosyl-beta-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor","volume":"30","author":"Yun","year":"2003","journal-title":"Nucl Med Biol"},{"key":"R32-3-20210212","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1023\/A:1010684101509","article-title":"Simplified labeling approach for synthesizing 3\u2032-deoxy-3\u2032-[F-18] flurothymidine [F-18]FLT","volume":"243","author":"Machulla","year":"2000","journal-title":"J Radioanal Nucl Chem"},{"key":"R33-3-20210212","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.nucmedbio.2004.01.008","article-title":"Fully automated synthesis system of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine","volume":"31","author":"Oh","year":"2004","journal-title":"Nucl Med Biol"},{"key":"R34-3-20210212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.apradiso.2005.07.017","article-title":"Semiautomatic synthesis of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine using three precursors","volume":"64","author":"Teng","year":"2006","journal-title":"Appl Radiat Isot"},{"key":"R35-3-20210212","first-page":"274","article-title":"Kinetic analysis of 3\u2032-deoxy-3\u2032-fluorothymidine PET studies: validation studies in patients with lung cancer","volume":"46","author":"Muzi","year":"2005","journal-title":"J Nucl Med"},{"key":"R36-3-20210212","first-page":"1612","article-title":"Kinetic analysis of 3\u2032-deoxy-3\u2032-18F-fluorothymidine in patients with gliomas","volume":"47","author":"Muzi","year":"2006","journal-title":"J Nucl Med"},{"key":"R37-3-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00259-008-0960-5","article-title":"Reproducibility of quantitative 18F-3\u2032-deoxy-3\u2032-fluorothymidine measurements using positron emission tomography","volume":"36","author":"De Langen","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R38-3-20210212","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00259-007-0379-4","article-title":"Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3\u2032-deoxy-3\u2032-[(18)F]fluorothymidine positron emission tomography","volume":"34","author":"Kenny","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R39-3-20210212","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1158\/1078-0432.CCR-07-5243","article-title":"Analysis and reproducibility of 3\u2032-Deoxy-3\u2032-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer","volume":"14","author":"Shields","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R40-3-20210212","first-page":"2027","article-title":"Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs","volume":"44","author":"Schwartz","year":"2003","journal-title":"J Nucl Med"},{"key":"R41-3-20210212","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0969-8051(02)00286-X","article-title":"Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines","volume":"29","author":"Toyohara","year":"2002","journal-title":"Nucl Med Biol"},{"key":"R42-3-20210212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00259-004-1611-0","article-title":"The uptake of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels","volume":"32","author":"Barthel","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R43-3-20210212","first-page":"400","article-title":"Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer","volume":"46","author":"Van Westreenen","year":"2005","journal-title":"J Nucl Med"},{"key":"R44-3-20210212","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00259-005-0011-4","article-title":"Use of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors","volume":"33","author":"Yang","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R45-3-20210212","first-page":"1754","article-title":"Evaluation of 3\u2032-deoxy-3\u2032-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice","volume":"45","author":"Sugiyama","year":"2004","journal-title":"J Nucl Med"},{"key":"R46-3-20210212","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11307-007-0104-5","article-title":"Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2\u2032-deoxy-2\u2032-[18F]fluoro-D-glucose (FDG) and 3\u2032-[18F]fluoro-3\u2032-deoxythymidine (FLT)","volume":"9","author":"Molthoff","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"R47-3-20210212","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/0008-5472.CAN-04-4008","article-title":"Early detection of tumor response to chemotherapy by 3\u2032-deoxy-3\u2032-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo","volume":"65","author":"Leyton","year":"2005","journal-title":"Cancer Res"},{"key":"R48-3-20210212","first-page":"3791","article-title":"3\u2032-deoxy-3\u2032-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography","volume":"63","author":"Barthel","year":"2003","journal-title":"Cancer Res"},{"key":"R49-3-20210212","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s00259-002-0925-z","article-title":"Early changes in [18F]FLT uptake after chemotherapy: an experimental study","volume":"29","author":"Dittmann","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R50-3-20210212","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00259-007-0452-z","article-title":"Early assessment of therapy response in malignant lymphoma with the thymidine analogue [(18)F]FLT","volume":"34","author":"Buck","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R51-3-20210212","first-page":"114","article-title":"Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3\u2032-deoxy-3\u2032-18F-fluorothymidine PET","volume":"46","author":"Waldherr","year":"2005","journal-title":"J Nucl Med"},{"key":"R52-3-20210212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11307-008-0162-3","article-title":"Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment","volume":"10","author":"Graf","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"R53-3-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11307-008-0158-z","article-title":"FLT-PET imaging of radiation responses in murine tumors","volume":"10","author":"Pan","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"R54-3-20210212","first-page":"1757","article-title":"Carbon-11-thymidine and FDG to measure therapy response","volume":"39","author":"Shields","year":"1998","journal-title":"J Nucl Med"},{"key":"R55-3-20210212","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1089\/1084978041979652","article-title":"[18F]3\u2032-deoxy-3\u2032-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations \u2013 a pilot study","volume":"19","author":"Buchmann","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"R56-3-20210212","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s00259-003-1187-0","article-title":"Potential impact of [18F]3\u2032-deoxy-3\u2032-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer","volume":"30","author":"Francis","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R57-3-20210212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejso.2005.09.011","article-title":"Positron emission tomography in patients with breast cancer using (18)F-3\u2032-deoxy-3\u2032-fluoro-l-thymidine [(18)F-FLT]-a pilot study","volume":"32","author":"Been","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"R58-3-20210212","first-page":"945","article-title":"Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG","volume":"46","author":"Chen","year":"2005","journal-title":"J Nucl Med"},{"key":"R59-3-20210212","first-page":"1948","article-title":"18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors","volume":"46","author":"Jacobs","year":"2005","journal-title":"J Nucl Med"},{"key":"R60-3-20210212","first-page":"2681","article-title":"3\u2032-[18F]fluoro-3\u2032-deoxythymidine [(18F)-FLT] as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease","volume":"63","author":"Wagner","year":"2003","journal-title":"Cancer Res"},{"key":"R61-3-20210212","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00259-004-1462-8","article-title":"PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study","volume":"31","author":"Smyczek-Gargya","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R62-3-20210212","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1158\/1078-0432.CCR-03-0040","article-title":"Detection and grading of soft tissue sarcomas of the extremities with (18)F-3\u2032-fluoro-3\u2032-deoxy-L-thymidine","volume":"10","author":"Cobben","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R63-3-20210212","first-page":"3331","article-title":"3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules","volume":"62","author":"Buck","year":"2002","journal-title":"Cancer Res"},{"key":"R64-3-20210212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1378\/chest.129.2.393","article-title":"Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography","volume":"129","author":"Yap","year":"2006","journal-title":"Chest"},{"key":"R65-3-20210212","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/gut.52.11.1602","article-title":"In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography","volume":"52","author":"Francis","year":"2003","journal-title":"Gut"},{"key":"R66-3-20210212","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1158\/0008-5472.CAN-06-1955","article-title":"Molecular imaging of proliferation in malignant lymphoma","volume":"66","author":"Buck","year":"2006","journal-title":"Cancer Res"},{"key":"R67-3-20210212","first-page":"1677","article-title":"Is 18F-3\u2032-fluoro-3\u2032-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?","volume":"45","author":"Cobben","year":"2004","journal-title":"J Nucl Med"},{"key":"R68-3-20210212","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-004-1706-7","article-title":"Clinical relevance of imaging proliferative activity in lung nodules","volume":"32","author":"Buck","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R69-3-20210212","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.107.044966","article-title":"A multicenter clinical trial on the diagnostic value of dual-tracer PET\/CT in pulmonary lesions using 3\u2032-deoxy-3\u2032-18F-fluorothymidine and 18F-FDG","volume":"49","author":"Tian","year":"2008","journal-title":"J Nucl Med"},{"key":"R70-3-20210212","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/10428190601113568","article-title":"Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET","volume":"48","author":"Kasper","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R71-3-20210212","first-page":"226","article-title":"18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET","volume":"45","author":"Cobben","year":"2004","journal-title":"J Nucl Med"},{"key":"R72-3-20210212","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2967\/jnumed.106.037473","article-title":"18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients","volume":"48","author":"Troost","year":"2007","journal-title":"J Nucl Med"},{"key":"R73-3-20210212","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00259-008-0847-5","article-title":"11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma","volume":"35","author":"Hatakeyama","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R74-3-20210212","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00259-004-1742-3","article-title":"[18F]3\u2032-deoxy-3\u2032-fluorothymidine PET for the diagnosis and grading of brain tumors","volume":"32","author":"Choi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R75-3-20210212","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00259-006-0354-5","article-title":"18F-fluorothymidine kinetics of malignant brain tumors","volume":"34","author":"Schiepers","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R76-3-20210212","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1158\/1078-0432.CCR-07-1553","article-title":"Glioma proliferation as assessed by 3\u2032-fluoro-3\u2032-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma","volume":"14","author":"Ullrich","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R77-3-20210212","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations","volume":"5","author":"Patlak","year":"1985","journal-title":"J Cereb Blood Flow Metab"},{"key":"R78-3-20210212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11307-005-0029-9","article-title":"Usefulness of 3\u2032-[F-18]fluoro-3\u2032-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy","volume":"8","author":"Pio","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"R79-3-20210212","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1158\/1078-0432.CCR-06-3025","article-title":"Early response assessment using 3\u2032-deoxy-3\u2032-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin\u2032s lymphoma","volume":"13","author":"Herrmann","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R80-3-20210212","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1158\/1078-0432.CCR-08-0312","article-title":"[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung","volume":"14","author":"Sohn","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R81-3-20210212","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00259-006-0292-2","article-title":"PET imaging with [(18)F]3\u2032-deoxy-3\u2032-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer","volume":"34","author":"Wieder","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R82-3-20210212","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1200\/JCO.2006.10.5825","article-title":"Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study","volume":"20","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"R83-3-20210212","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.2967\/jnumed.107.046391","article-title":"Imaging of cell proliferation: status and prospects","volume":"49","author":"Bading","year":"2008","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-200912000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T14:45:39Z","timestamp":1710686739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-200912000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":83,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32832ee93b","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}